|Articles|June 8, 2020
Managing the COVID-19 Drug Safety Response
Author(s)MyMeds&Me
Current safety reporting systems cannot meet the demands of a COVID-19 response. Find out how digital transformation enables rapid understanding & management of drug safety.
Related Content
Trending on PharmExec
1
The Agentic AI Revolution in Biopharma
2
How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications
3
Novartis Investors Share Concerns Over M&A Strategy: Report
4
Artisan Partners’ Director Calls for Novartis Board Shake-Up
5